Back to search

Article

Intra-tumor heterogeneity defines treatment-resistant HER2+ breast tumors

2018-04-18

Abstract excerpt

Targeted therapy for patients with HER2 positive (HER2+) breast cancer has improved the overall survival, but many patients still suffer relapse and death of the disease. Intra-tumor heterogeneity of both estrogen receptor (ER) and HER2 expression has been proposed to play a key role in treatment failure, but little work has been done to comprehensively study this heterogeneity at the single-cell level. In this st...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4ef90697-5d25-526e-ab64-7111cf4a2c78
DOI
10.1101/297549
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Intra-tumor heterogeneity defines treatment-resistant HER2+ breast tumorsDOI 10.1101/297549
Select a neighboring publication to make it the new centre.